TAUG Financials 07/16/2014 19:29:46
Tauriga Sciences, Inc.
Period Ending Mar 31, 2013 Mar 31, 2012 Mar 31, 2011 Mar 31, 2010
Total Revenue - - - -
Cost of Revenue - - - -
Gross Profit - - - -
Operating Expenses
Research and Development - - 471 515
Sales, General and Admin. 8,374 3,767 1,763 2,347
Non-Recurring Items 2,714 819 - -
Other 44 3 4 1
Operating Income (11,132) (4,589) (2,238) (2,863)
Income From Continuing Operations
Add'l Income/Expense Items (4) - - -
Earnings Before Interest and Tax (11,136) (4,589) (2,238) (2,863)
Interest Expense 11 6 574 72
Earnings Before Tax (11,147) (4,595) (2,812) (2,936)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (11,147) (4,595) (2,812) (2,936)
Non Recurring Events
Discontinued Operations - (1,651) - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (11,147) (6,246) (2,812) (2,936)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (11,147) (6,246) (2,812) (2,936)